Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference Life Science Investing
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase Life Science Investing
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones Life Science Investing
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 Life Science Investing
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women Life Science Investing
